November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

New Imaging Nomogram Shows Promise in Predicting Small Cell Lung Cancer Chemotherapy Response

🧠 AI Analysis 2 min read 👁 4

A recent dual-center study published in Nature Health Sciences describes a CT-based model combining habitat imaging and peritumoral radiomics to predict patient response to platinum-based chemotherapy in small cell lung cancer.

🧠AI Analysis

Key points

  • Dual-center study evaluated 315 small cell lung cancer patients receiving platinum-based chemotherapy.
  • An integrated nomogram combined clinical features, peritumoral radiomics, and habitat imaging.
  • The model achieved strong validation AUC scores of up to 0.911 in external testing datasets.

Researchers from the First Affiliated Hospital of Soochow University and Zhongnan Hospital of Wuhan University have developed and validated an advanced imaging model designed to forecast how small cell lung cancer (SCLC) patients will respond to first-line platinum-based chemotherapy. Published in Nature Health Sciences, the retrospective study evaluated data from 315 patients divided into separate training and validation cohorts across two clinical centers. By examining both intratumoral habitats and the surrounding tissue microenvironment—specifically identifying a 0 to 3 millimeter peritumoral margin as optimal—the team constructed an integrated nomogram combining clinical-imaging features, peritumoral radiomics, and habitat details.

The resulting predictive tool demonstrated strong statistical performance, achieving area under the curve (AUC) values of 0.987 in the training group, 0.909 in internal validation, and 0.911 in external validation. While the findings suggest that advanced computerized tomography analysis may help clinicians anticipate treatment efficacy before therapy begins, the retrospective nature of the design and the need for broader prospective validation represent important limitations that require caution.

What to know: The dual-center study utilized machine learning and logistic regression on CT scans to gauge chemotherapy sensitivity in SCLC patients. Readers facing personal medical decisions should always consult a qualified healthcare professional.

Source Nature Health Sciences — nature.com/articles/s41598-026-75634-6 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.